Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery

Area of Science:

• Neurobiology
• Molecular Biology
• Yeast Genetics

Background:

• Amyloids are protein aggregates linked to neurodegenerative diseases.
• Prions are transmissible protein isoforms, often amyloid in nature.
• Yeast prions share properties with human disease-related amyloids.

Purpose of the Study:

• Investigate conserved cellular pathways in yeast to understand amyloid and prion formation.
• Identify environmental and physiological factors influencing protein aggregation.
• Explore yeast models for high-throughput drug screening against neurodegenerative diseases.

Main Methods:

• Utilized yeast as a model organism to study protein aggregation and prion phenomena.
• Examined conserved protein quality control pathways (chaperones, proteasome, autophagy).
• Investigated the impact of environmental stresses and heterologous inducers on prion formation.

Main Results:

• Identified key cellular proteins and conditions affecting amyloid and prion aggregation in yeast.
• Demonstrated that environmental stresses can trigger or resolve amyloid formation.
• Showcased yeast models as effective tools for screening therapeutic compounds.

Conclusions:

• Conserved cellular systems in yeast provide insights into human amyloid diseases.
• Environmental and physiological regulation of yeast prions suggests novel therapeutic strategies.
• Targeting common cellular pathways offers a promising approach for treating neurodegenerative amyloid diseases.